Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (111-120 of 244) with videos related to

Pageof 25
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1994
Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agentA L Ellis, B Nowak, W Plunkett, et al.
Psychological Assessment|December 5, 2017
Evaluating the eight-item Patient Health Questionnaire's psychometric properties with Mexican and Central American descent university studentsDavid Alpizar, Luciana Laganá, Scott W Plunkett, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 1996
Intracellular pharmacodynamics in leukemia therapyV Gandhi, E H Estey, M J Keating, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacologyV Gandhi, L E Robertson, M J Keating, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 1991
A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluidsA Kemena, M Fernandez, J Bauman, et al.
Molecular Pharmacology|November 14, 1997
Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistanceL Li, M J Keating, W Plunkett, et al.
Journal of the National Cancer Institute|September 12, 1992
Retinoids and cancer therapyD F Claxton, W Plunkett, M Andreeff, et al.
Journal of Consulting and Clinical Psychology|October 1, 1977
Children's social judgments concerning emotionally disturbed peersG Marsden, N Kalter, J W Plunkett, et al.
Cancer Research|July 15, 1988
Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosineV Heinemann, L W Hertel, G B Grindey, et al.
Cancer Research|December 26, 2001
Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damageG Achanta, H Pelicano, L Feng, et al.
Pageof 25

Showing results (111-120 of 244) with videos related to

Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|January 1, 1994
Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agentA L Ellis, B Nowak, W Plunkett, et al.
Psychological Assessment|December 5, 2017
Evaluating the eight-item Patient Health Questionnaire's psychometric properties with Mexican and Central American descent university studentsDavid Alpizar, Luciana Laganá, Scott W Plunkett, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 1996
Intracellular pharmacodynamics in leukemia therapyV Gandhi, E H Estey, M J Keating, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacologyV Gandhi, L E Robertson, M J Keating, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 1991
A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluidsA Kemena, M Fernandez, J Bauman, et al.
Molecular Pharmacology|November 14, 1997
Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistanceL Li, M J Keating, W Plunkett, et al.
Journal of the National Cancer Institute|September 12, 1992
Retinoids and cancer therapyD F Claxton, W Plunkett, M Andreeff, et al.
Journal of Consulting and Clinical Psychology|October 1, 1977
Children's social judgments concerning emotionally disturbed peersG Marsden, N Kalter, J W Plunkett, et al.
Cancer Research|July 15, 1988
Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosineV Heinemann, L W Hertel, G B Grindey, et al.
Cancer Research|December 26, 2001
Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damageG Achanta, H Pelicano, L Feng, et al.
Pageof 25